Investors
Key Stats
- 2,200+ procedures performed
- $32M+ in gross revenue to date
- 40%+ operating margins
- Global market projected to reach $213+ Billion by 2033
Capital Raise
- Reg D 506(c) offering for accredited investors
- $25M target raise
- IRR: 24%+ (3x ROI forecast in 3–5 years)
- Equity conversion options and preferred distribution structure
Use of Funds
- Launch 250 RE•LIFT™ Centers
- Expand ReStore Me™ & ReFresh Me™ product lines
- National advertising and B2B provider recruitment
Become an Investor
ReLiftMD™ offers a unique opportunity to participate in the future of aesthetics. Our business model combines IP-backed procedures, a certified provider network, and recurring product revenue from skincare, consumables, and memberships.